发明名称 PROTECTION OF ENDOGENOUS THERAPEUTIC PEPTIDES FROM PEPTIDASE ACTIVITY THROUGH CONJUGATION TO BLOOD COMPONENTS
摘要 <p>A method for protecting a peptide from peptidase activity in vivo, the peptide being composed of between 2 and 50 amino acids and having a C-terminus and an N-terminus and a C-terminus amino acid and an N-terminus amino acid is described. In the first step of the method, the peptide is modified by attaching a reactive group to the C-terminus amino acid, to the N-terminus amino acid, or to an amino acid located between the N-terminus and the C-terminus, such that the modified peptide is capable of forming a covalent bond in vivo with a reactive functionality on a blood component. In the next step, a covalent bond is formed between the reactive group and a reactive functionality on a blood component to form a peptide-blood component conjugate, thereby protecting said peptide from peptidase activity. The final step of the method involves the analyzing of the stability of the peptide-blood component conjugate to assess the protection of the peptide from peptidase activity.</p>
申请公布号 SI1105409(T1) 申请公布日期 2006.06.30
申请号 SI20000030836T 申请日期 2000.05.17
申请人 CONJUCHEM, INC. 发明人 BRIDON DOMINIQUE P.;EZRIN ALAN M.;MILNER PETER G.;HOLMES DARREN L.;THIBAUDEAU KAREN
分类号 A61K47/42;A61K38/00;A61K38/02;A61K47/48;A61P1/18;A61P5/00;A61P25/00;A61P25/28;A61P43/00;C07K1/107;C07K1/113;C07K1/14;C07K2/00;C07K7/00;C07K14/00;C07K14/16;C07K14/465;C07K14/575;C07K14/605;C07K14/645 主分类号 A61K47/42
代理机构 代理人
主权项
地址